7-(4-Chlorobutoxy)quinolin-2(1H)-enye CAS 913613-82-8 Ucoceko >98.0% (HPLC) Brexpiprazole Intermediate Factory Featured Image

7-(4-Chlorobutoxy)quinolin-2(1H)-enye CAS 913613-82-8 Ubunyulu>98.0% (HPLC) Brexpiprazole Intermediate Factory

Inkcazelo emfutshane:

Igama: 7-(4-Chlorobutoxy)quinolin-2(1H)-enye

CAS: 913613-82-8

Ubunyulu: >98.0% (HPLC)

Imbonakalo: Mthubi oMthubi ukuya kwiPale Beige eSolid

Umbindi weBrexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-enye CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Iipropati zeMichiza:

Igama leMchiza	7-(4-Chlorobutoxy)quinolin-2(1H)-enye
Izithethantonye	I-7-(4-Chlorobutoxy) -1H-Quinolin-2-enye;Ukungacoceki kweBrexpiprazole 23
Inombolo yeCAS	913613-82-8
Inombolo yeCAT	RF-PI1980
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	I-C13H14ClNO2
Ubunzima beMolekyuli	251.71
Indawo yokubilisa	460.8±45.0℃
Ukuxinana	1.216±0.06 g/cm3
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Mthubi oMthubi ukuya kwiPale Beige eSolid
Ubunyulu / Indlela yokuHlalutya	>98.0% (HPLC)
I-Infrared Spectrum	Iyahambelana neSakhiwo
NMR	Iyahambelana neSakhiwo
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Phakathi / Ukungcola kweBrexpiprazole (CAS: 913611-97-9)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

FAQ:

Isicelo:

I-7-(4-Chlorobutoxy) i-quinolin-2 (1H)-enye (i-CAS: 913613-82-8) iphakathi / ukungcola kweBrexpiprazole (CAS: 913611-97-9).I-Brexpiprazole lichiza le-atypical antipsychotic.Yi-D2 dopamine partial agonist ebizwa ngokuba yi-serotonin-dopamine activity modulator (SDAM).Ichiza lifumene imvume ye-FDA ngoJulayi 13, 2015 kunyango lwe-schizophrenia, kwaye njengonyango olongezelelweyo loxinzelelo.Nangona i-Brexpiprazole yasilela kwiSigaba sesi-II solingo lwezonyango lwe-ADHD, i-Brexpiprazole yenzelwe ukubonelela ngokusebenza okuphuculweyo kunye nokunyamezela (umzekelo, i-akathisia engaphantsi, ukungazinzi kunye / okanye ukuphuthelwa) ngaphezu konyango olumiselweyo lwe-depressive disorder (MDD).